AU2003229181A1 - Stable dosage forms comprising atorvastatin calcium - Google Patents

Stable dosage forms comprising atorvastatin calcium

Info

Publication number
AU2003229181A1
AU2003229181A1 AU2003229181A AU2003229181A AU2003229181A1 AU 2003229181 A1 AU2003229181 A1 AU 2003229181A1 AU 2003229181 A AU2003229181 A AU 2003229181A AU 2003229181 A AU2003229181 A AU 2003229181A AU 2003229181 A1 AU2003229181 A1 AU 2003229181A1
Authority
AU
Australia
Prior art keywords
dosage forms
atorvastatin calcium
stable dosage
stable
atorvastatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003229181A
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003229181A1 publication Critical patent/AU2003229181A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003229181A 2002-05-21 2003-05-15 Stable dosage forms comprising atorvastatin calcium Abandoned AU2003229181A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,385,529 2002-05-21
CA 2385529 CA2385529A1 (en) 2002-05-21 2002-05-21 Stable dosage forms comprising atorvastatin calcium
PCT/CA2003/000710 WO2003097039A1 (en) 2002-05-21 2003-05-15 Stable dosage forms comprising atorvastatin calcium

Publications (1)

Publication Number Publication Date
AU2003229181A1 true AU2003229181A1 (en) 2003-12-02

Family

ID=29425923

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003229181A Abandoned AU2003229181A1 (en) 2002-05-21 2003-05-15 Stable dosage forms comprising atorvastatin calcium

Country Status (3)

Country Link
AU (1) AU2003229181A1 (en)
CA (1) CA2385529A1 (en)
WO (1) WO2003097039A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2465693A1 (en) * 2003-06-12 2004-12-12 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
WO2006059224A1 (en) * 2004-12-02 2006-06-08 Warner-Lambert Company Llc Pharmaceutical compositions of amorphous atorvastatin and process for preparing same
EP1810667A1 (en) * 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising amorphous atorvastatin
WO2013072770A2 (en) 2011-11-15 2013-05-23 Dr. Reddy's Laboratories Ltd. Pharmaceutical formulations comprising atorvastatin and glimepiride
WO2014008374A2 (en) * 2012-07-06 2014-01-09 Thetis Pharmaceuticals Llc Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
ATE178794T1 (en) * 1993-01-19 1999-04-15 Warner Lambert Co STABILIZED ORAL COMPOSITION CONTAINING THE COMPOUND CI-981 AND METHOD
SI20109A (en) * 1998-12-16 2000-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Stable pharmaceutical formulation
ES2401598T3 (en) * 2000-04-10 2013-04-22 Teva Pharmaceutical Industries, Ltd. Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
SK16982002A3 (en) * 2000-06-09 2003-04-01 Lek Pharmaceuticals D. D. Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
SI20814A (en) * 2001-01-23 2002-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Preparation of amorphous atorvastatin
SI20848A (en) * 2001-03-14 2002-10-31 Lek, Tovarna Farmacevtskih In Kemijskih Izdelkov, D.D. Pharmaceutical formulation containing atorvastatin calcium

Also Published As

Publication number Publication date
CA2385529A1 (en) 2003-11-21
WO2003097039A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
GB0218625D0 (en) Pharmaceutical compounds
AU2003291103A1 (en) Pharmaceutical composition
AU2003225031A1 (en) Eptfe-reinforced perfluoroelastomers
PL373806A1 (en) Novel physiolgically active substances
AU2003250372A1 (en) Pharmaceutical composition
EP1548121A4 (en) Novel physiologically active substances
GB0215775D0 (en) Pharmaceutical compounds
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003216053A1 (en) Guanidino compounds
AU2003206718A1 (en) Dosage dispenser
AU2003218170A1 (en) Autoinducer compounds
AU2002353739A1 (en) Therapeutic compounds
AU2003215150A1 (en) Therapeutic compounds
AU2003228198A1 (en) Av-fistula bandage
AU2002353659A1 (en) Simvastatin dosage forms
AU2003260067A1 (en) Dosage forms having reduced moisture transmission
AU2003211586A1 (en) Drugs containing riboflavin-type compounds
AU2003298582A1 (en) Therapeutic guanidines
AU2003229181A1 (en) Stable dosage forms comprising atorvastatin calcium
AUPS015802A0 (en) Fumigant formulation
AU2003284460A1 (en) Medicinal composition
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003213948A1 (en) Stable tablets comprising simvastatin
AU2003280799A1 (en) Medicinal composition
AU2003216503A1 (en) Stable pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase